Clinical Trials Browser

Phase 2 × Amyloidosis × Etanercept × Clear all

NCT00224393 2023-05-30

Phase II Trial of Enbrel in Patients With Primary Systemic Amyloidosis

Phase 2 Completed

Immunoglobulin Light-chain Amyloidosis, Amyloidosis